FDA Inspection
Mylan Laboratories Limited (FDF-2)Mylan Laboratories Limited (FDF-2) – FDA Inspection, Feb 3, 2023
Record Details
This FDA Inspection record concerns Mylan Laboratories Limited (FDF-2), with an inspection on February 3, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c86b2c6d-3939-43ca-9c49-3ab1f5c1b33f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1253435
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Mylan Laboratories Limited (FDF-2)
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 16, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mylan Laboratories Limited (FDF-2)
- FDA Inspection 1122884 - 2020-02-28
- FDA Inspection 1091217 - 2019-04-26
- FDA Inspection 1012796 - 2017-05-26
- FDA Inspection 884211 - 2014-05-16
- FDA Inspection 775616 - 2012-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.